vs
Side-by-side financial comparison of AMERICAN AXLE & MANUFACTURING HOLDINGS INC (AXL) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
AMERICAN AXLE & MANUFACTURING HOLDINGS INC is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.2× PERRIGO Co plc). AMERICAN AXLE & MANUFACTURING HOLDINGS INC runs the higher net margin — -5.4% vs -127.8%, a 122.4% gap on every dollar of revenue. On growth, AMERICAN AXLE & MANUFACTURING HOLDINGS INC posted the faster year-over-year revenue change (0.2% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $54.7M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -7.2%).
American Axle & Manufacturing, Inc. (AAM), headquartered in Detroit, Michigan, is an American manufacturer of automobile driveline and drivetrain components and systems.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
AXL vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.1B |
| Net Profit | $-75.3M | $-1.4B |
| Gross Margin | 10.2% | 32.6% |
| Operating Margin | -2.4% | -116.0% |
| Net Margin | -5.4% | -127.8% |
| Revenue YoY | 0.2% | -2.5% |
| Net Profit YoY | -449.6% | -3093.9% |
| EPS (diluted) | $-0.62 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.6B | $1.1B |
| Q4 25 | $-75.3M | $-1.4B | ||
| Q3 25 | $9.2M | $7.5M | ||
| Q2 25 | $39.3M | $-8.4M | ||
| Q1 25 | $7.1M | $-6.4M | ||
| Q4 24 | $-13.7M | $-44.4M | ||
| Q3 24 | $10.0M | $-21.0M | ||
| Q2 24 | $18.2M | $-108.4M | ||
| Q1 24 | $20.5M | $2.0M |
| Q4 25 | 10.2% | 32.6% | ||
| Q3 25 | 12.6% | 36.1% | ||
| Q2 25 | 13.1% | 34.4% | ||
| Q1 25 | 12.3% | 37.6% | ||
| Q4 24 | 11.2% | 33.9% | ||
| Q3 24 | 11.4% | 37.2% | ||
| Q2 24 | 13.3% | 37.0% | ||
| Q1 24 | 12.4% | 33.1% |
| Q4 25 | -2.4% | -116.0% | ||
| Q3 25 | 3.2% | 7.0% | ||
| Q2 25 | 3.6% | 4.3% | ||
| Q1 25 | 3.0% | 4.5% | ||
| Q4 24 | 2.6% | 10.0% | ||
| Q3 24 | 2.8% | 7.4% | ||
| Q2 24 | 5.3% | -2.5% | ||
| Q1 24 | 4.8% | -5.1% |
| Q4 25 | -5.4% | -127.8% | ||
| Q3 25 | 0.6% | 0.7% | ||
| Q2 25 | 2.6% | -0.8% | ||
| Q1 25 | 0.5% | -0.6% | ||
| Q4 24 | -1.0% | -3.9% | ||
| Q3 24 | 0.7% | -1.9% | ||
| Q2 24 | 1.1% | -10.2% | ||
| Q1 24 | 1.3% | 0.2% |
| Q4 25 | $-0.62 | $-10.23 | ||
| Q3 25 | $0.07 | $0.05 | ||
| Q2 25 | $0.32 | $-0.06 | ||
| Q1 25 | $0.06 | $-0.05 | ||
| Q4 24 | $-0.11 | $-0.32 | ||
| Q3 24 | $0.08 | $-0.15 | ||
| Q2 24 | $0.15 | $-0.79 | ||
| Q1 24 | $0.17 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $708.9M | — |
| Total DebtLower is stronger | $4.0B | — |
| Stockholders' EquityBook value | $640.0M | $2.9B |
| Total Assets | $6.7B | $8.5B |
| Debt / EquityLower = less leverage | 6.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $708.9M | — | ||
| Q3 25 | $714.1M | $432.1M | ||
| Q2 25 | $586.5M | $454.2M | ||
| Q1 25 | $549.2M | $409.9M | ||
| Q4 24 | $552.9M | $558.8M | ||
| Q3 24 | $542.5M | $1.5B | ||
| Q2 24 | $519.9M | $542.8M | ||
| Q1 24 | $469.8M | $658.5M |
| Q4 25 | $4.0B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $640.0M | $2.9B | ||
| Q3 25 | $718.4M | $4.4B | ||
| Q2 25 | $673.0M | $4.5B | ||
| Q1 25 | $596.3M | $4.4B | ||
| Q4 24 | $562.8M | $4.3B | ||
| Q3 24 | $616.3M | $4.6B | ||
| Q2 24 | $609.6M | $4.5B | ||
| Q1 24 | $621.4M | $4.7B |
| Q4 25 | $6.7B | $8.5B | ||
| Q3 25 | $5.3B | $10.1B | ||
| Q2 25 | $5.3B | $10.1B | ||
| Q1 25 | $5.1B | $9.8B | ||
| Q4 24 | $5.1B | $9.6B | ||
| Q3 24 | $5.3B | $11.2B | ||
| Q2 24 | $5.3B | $10.4B | ||
| Q1 24 | $5.4B | $10.6B |
| Q4 25 | 6.31× | — | ||
| Q3 25 | 3.61× | — | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 4.38× | — | ||
| Q4 24 | 4.58× | — | ||
| Q3 24 | 4.28× | — | ||
| Q2 24 | 4.42× | — | ||
| Q1 24 | 4.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.5M | $175.4M |
| Free Cash FlowOCF − Capex | $54.7M | $148.6M |
| FCF MarginFCF / Revenue | 4.0% | 13.4% |
| Capex IntensityCapex / Revenue | 4.8% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $155.1M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.5M | $175.4M | ||
| Q3 25 | $143.3M | $51.7M | ||
| Q2 25 | $91.9M | $75.9M | ||
| Q1 25 | $55.9M | $-64.5M | ||
| Q4 24 | $151.2M | $312.6M | ||
| Q3 24 | $143.6M | $42.2M | ||
| Q2 24 | $142.8M | $9.5M | ||
| Q1 24 | $17.8M | $-1.4M |
| Q4 25 | $54.7M | $148.6M | ||
| Q3 25 | $79.2M | $29.8M | ||
| Q2 25 | $34.6M | $56.7M | ||
| Q1 25 | $-13.4M | $-90.0M | ||
| Q4 24 | $73.2M | $274.9M | ||
| Q3 24 | $70.4M | $15.1M | ||
| Q2 24 | $94.0M | $-18.9M | ||
| Q1 24 | $-30.2M | $-26.5M |
| Q4 25 | 4.0% | 13.4% | ||
| Q3 25 | 5.3% | 2.9% | ||
| Q2 25 | 2.3% | 5.4% | ||
| Q1 25 | -0.9% | -8.6% | ||
| Q4 24 | 5.3% | 24.2% | ||
| Q3 24 | 4.7% | 1.4% | ||
| Q2 24 | 5.8% | -1.8% | ||
| Q1 24 | -1.9% | -2.4% |
| Q4 25 | 4.8% | 2.4% | ||
| Q3 25 | 4.3% | 2.1% | ||
| Q2 25 | 3.7% | 1.8% | ||
| Q1 25 | 4.9% | 2.4% | ||
| Q4 24 | 5.6% | 3.3% | ||
| Q3 24 | 4.9% | 2.5% | ||
| Q2 24 | 3.0% | 2.7% | ||
| Q1 24 | 3.0% | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | 15.58× | 6.89× | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 7.87× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 14.36× | — | ||
| Q2 24 | 7.85× | — | ||
| Q1 24 | 0.87× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
